Clinical Trial Update: A Study of JNJ-95597528 in Participants With Moderate to Severe Atopic Dermatitis [Phase 2]

View source ↗

Summary

This document reports a Phase 2 clinical trial evaluating JNJ-95597528 for moderate to severe atopic dermatitis, currently recruiting participants.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• JNJ-95597528

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Dermatitis, Atopic | Phase 2 | Status: RECRUITING